Insider Trading & Ownership - Opus Genetics Inc. (IRD)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Opus Genetics Inc.
Goto 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-11-21
Purchase
2024-11-25
4:18 pm
Opus Genetics Inc.IRDYERXA BENJAMIN R
President
10,000$0.9834$9,834342,800
(Direct)
View
2024-11-15
Purchase
2024-11-19
4:08 pm
Opus Genetics Inc.IRDMagrath George
Chief Executive Officer
100,000$1.0116$101,158492,950
(Direct)
View
2024-05-22
Purchase
2024-05-24
4:07 pm
Ocuphire Pharma Inc.OCUPJayagopal Ashwath
Chief Scientific & Dev. Ofc.
3,500$1.765$6,17878,500
(Direct)
View
2024-05-17
Purchase
2024-05-21
4:18 pm
Ocuphire Pharma Inc.OCUPMagrath George
Chief Executive Officer
5,000$1.7545$8,773430,000
(Direct)
View
2024-03-21
Purchase
2024-03-25
4:44 pm
Ocuphire Pharma Inc.OCUPSCHACHLE JOSEPH K
Chief Operating Officer
2,000$2.05$4,1002,000
(Direct)
View
2024-03-21
Purchase
2024-03-25
4:40 pm
Ocuphire Pharma Inc.OCUPJhaveri Nirav S.
Chief Financial Officer
10,000$2.1$21,000150,000
(Direct)
View
2024-03-18
Purchase
2024-03-20
4:18 pm
Ocuphire Pharma Inc.OCUPMagrath George
Chief Executive Officer
25,000$1.962$49,050425,000
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-11-07
Option Award
2024-11-12
4:35 pm
N/A
N/A
Opus Genetics Inc.IRDYERXA BENJAMIN R
President
332,800$0332,800
(Direct)
View
2024-11-01
Tax Withholding
2024-11-05
4:13 pm
N/A
N/A
Opus Genetics Inc.IRDMagrath George
Chief Executive Officer
37,050$1.18392,950
(Direct)
View

Ownership
2024-10-29
5:10 pm
N/A
N/A
Opus Genetics Inc.IRDFoundation Fighting Blindness Retinal Degeneration Fund
Foundation Fighting Blindness Inc.
See Remarks
0$02,571,679
(Direct)
View
2024-10-22
Option Award
2024-10-24
5:59 pm
N/A
2034-10-21
Opus Genetics Inc.IRDGraves Adrienne L
Director
172,874$0172,874
(Direct)
View
2024-10-22
Option Award
2024-10-24
5:56 pm
N/A
2034-10-21
Opus Genetics Inc.IRDBennett Jean
Director
272,874$0272,874
(Direct)
View
2024-06-11
Option Award
2024-06-13
5:31 pm
N/A
2034-06-10
Ocuphire Pharma Inc.OCUPRodgers Richard J
Director
76,324$0274,332
(Direct)
View
2024-06-11
Option Award
2024-06-13
5:30 pm
N/A
2034-06-10
Ocuphire Pharma Inc.OCUPPepose Jay
Director
76,324$0215,639
(Direct)
View
2024-06-11
Option Award
2024-06-13
5:28 pm
N/A
2034-06-10
Ocuphire Pharma Inc.OCUPMANUSO JAMES S J
Director
76,324$0167,218
(Direct)
View
2024-06-11
Option Award
2024-06-13
5:27 pm
N/A
2034-06-10
Ocuphire Pharma Inc.OCUPGallagher Cam
Director
76,324$0112,228
(Direct)
View
2024-06-11
Option Award
2024-06-13
5:25 pm
N/A
2034-06-10
Ocuphire Pharma Inc.OCUPBenton Susan
Director
76,324$0175,204
(Direct)
View
2024-06-11
Option Award
2024-06-13
5:23 pm
N/A
2034-06-10
Ocuphire Pharma Inc.OCUPAinsworth Sean
Director
76,324$0123,539
(Direct)
View
2024-04-11
Option Award
2024-04-15
4:11 pm
N/A
2034-04-10
Ocuphire Pharma Inc.OCUPPepose Jay
Director
80,000$0187,315
(Direct)
View
2024-02-12
Option Award
2024-02-14
6:37 pm
N/A
2034-02-11
Ocuphire Pharma Inc.OCUPJhaveri Nirav S.
Chief Financial Officer
350,000$0350,000
(Direct)
View
2024-02-12
Option Award
2024-02-14
6:35 pm
N/A
2034-02-11
Ocuphire Pharma Inc.OCUPJayagopal Ashwath
Chief Scientific & Dev. Ofc.
300,000$0300,000
(Direct)
View
2024-01-18
Option Award
2024-01-22
6:01 pm
N/A
2034-01-17
Ocuphire Pharma Inc.OCUPHoffmann Bernhard
SVP of Corp. Dev.
50,000$0192,697
(Direct)
View
2024-01-18
Option Award
2024-01-22
6:01 pm
N/A
2034-01-17
Ocuphire Pharma Inc.OCUPZaremba Rabourn Amy
SVP of Finance
100,000$0142,658
(Direct)
View
2024-01-10
Tax Withholding
2024-01-12
4:17 pm
N/A
N/A
Ocuphire Pharma Inc.OCUPZaremba Rabourn Amy
SVP of Finance
3,950$3.26542,658
(Direct)
View
2024-01-10
Tax Withholding
2024-01-12
4:17 pm
N/A
N/A
Ocuphire Pharma Inc.OCUPPatel Ronil A.
Chief Business Officer
1,282$3.26590,714
(Direct)
View
2024-01-10
Tax Withholding
2024-01-12
4:17 pm
N/A
N/A
Ocuphire Pharma Inc.OCUPHoffmann Bernhard
SVP of Corp. Dev.
4,031$3.265142,697
(Direct)
View
2024-01-01
Option Award
2024-01-03
6:06 pm
N/A
N/A
Ocuphire Pharma Inc.OCUPPepose Jay
Director
14,964$0107,315
(Direct)
View
2024-01-01
Option Award
2024-01-03
6:04 pm
N/A
N/A
Ocuphire Pharma Inc.OCUPMANUSO JAMES S J
Director
22,090$090,894
(Direct)
View
2024-01-01
Option Award
2024-01-03
6:03 pm
N/A
N/A
Ocuphire Pharma Inc.OCUPRodgers Richard J
Director
24,762$0198,008
(Direct)
View
2024-01-01
Option Award
2024-01-03
5:57 pm
N/A
N/A
Ocuphire Pharma Inc.OCUPBenton Susan
Director
19,418$098,880
(Direct)
View
2023-12-01
Option Award
2023-12-05
4:30 pm
N/A
2033-11-30
Ocuphire Pharma Inc.OCUPPatel Ronil A.
Chief Business Officer
124,230$0166,534
(Direct)
View
2023-11-27
Option Award
2023-11-27
6:24 pm
N/A
2033-11-26
Ocuphire Pharma Inc.OCUPSCHACHLE JOSEPH K
Chief Operating Officer
300,000$0300,000
(Direct)
View
2023-11-01
Option Award
2023-11-13
5:46 pm
N/A
N/A
Ocuphire Pharma Inc.OCUPPepose Jay
Director
35,000$092,351
(Direct)
View
2023-11-01
Option Award
2023-11-13
5:42 pm
N/A
N/A
Ocuphire Pharma Inc.OCUPRodgers Richard J
Director
35,000$0173,246
(Direct)
View
Goto 0, 1, 2, 3, Next